EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis

Dylan A Levy, Ajibola B Bakare iD, Robert E Gurevich, Edward D McCoul

American Journal of Rhinology & Allergy · 2025

DOI: 10.1177/19458924251360917 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift American Journal of Rhinology & Allergy, 2025. Verfasst von Dylan A Levy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Tulane University School of Medicine, New Orleans, LA, USA. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic rhinitis (AR) affects millions of people worldwide, impacting quality of life and causing economic burden. Intranasal corticosteroids (INCs) are the mainstay treatment for AR, delivered via aerosol or aqueous sprays.

Objective

This systematic review and meta-analysis investigate the comparative efficacy and safety of aerosol and aqueous delivery methods in AR treatment.

Methods

Two independent reviewers searched 4 databases (Embrace, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and Web of Science) for English-language, prospective randomized controlled trial (RCT), comparing aqueous and aerosol INCs for AR treatment. Studies were excluded for specific reasons (wrong comparisons, full text unavailable, insufficient data for extraction, wrong patient population, incorrect route of administration (non-intranasal), unverifiable inclusion criteria). Primary outcomes were Total Nasal Symptom Score (TNSS) and subset scores; secondary outcome was adverse event (AEs).

Results

No significant difference in overall TNSS was found between the delivery methods. However, aqueous sprays showed a slight edge in reducing specific symptoms like congestion, itching, sneezing, and rhinorrhea. AEs did not differ significantly.

Conclusion

Our findings suggest no significant difference in efficacy or safety between aerosol and aqueous INCs for AR treatment. Patient preference should be a primary consideration when choosing a delivery method to optimize adherence and symptom control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicAdrenal Cortex HormonesHumansAdministration, IntranasalAerosolsNasal SpraysTreatment OutcomeRandomized Controlled Trials as TopicQuality of Life

Stichwörter der Autor:innen

adverse eventsaerosolallergic rhinitisallergyaqueousintranasal corticosteroidsquality of liferandomized controlled trialsspraystotal nasal symptom score

Substanzen

Adrenal Cortex HormonesAerosolsNasal Sprays

Autor:innen und Institutionen

  • Department of Otolaryngology, Tulane University School of Medicine, New Orleans, LA, USA.
  • Tulane University School of Medicine, New Orleans, LA, USA.
  • Department of Otorhinolaryngology, Ochsner Health, New Orleans, LA, USA.

ORCID-Profile: Ajibola B Bakare

Zitieren

APA

Levy, D. A., Bakare, A. B., Gurevich, R. E., & McCoul, E. D. (2025). Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis. American Journal of Rhinology & Allergy. https://doi.org/10.1177/19458924251360917

Vancouver

Levy DA, Bakare AB, Gurevich RE, McCoul ED. Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis. American Journal of Rhinology & Allergy. 2025. doi:10.1177/19458924251360917

BibTeX
@article{Levy2025,
  author = {Levy, Dylan A and Bakare, Ajibola B and Gurevich, Robert E and McCoul, Edward D},
  title = {Aqueous Versus Aerosol Intranasal Corticosteroid Spray for Allergic Rhinitis: Systematic Review and Meta-Analysis},
  journal = {American Journal of Rhinology & Allergy},
  year = {2025},
  doi = {10.1177/19458924251360917}
}
Kostenlos starten →